Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

992
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
992

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resolving the dilution paradox to improve the interpretation of extracellular vesicle biomarker studies.

Research and practice in thrombosis and haemostasis·2026
Same author

ADAMTS13 and von Willebrand Factor in relation to vascular cognitive impairment and cerebral small vessel disease: the heart-brain connection study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Validation of tRNA-derived fragments as diagnostic biomarkers in suspected acute stroke; limitations in analysis and quantification methods.

Molecular therapy. Nucleic acids·2025
Same author

Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular disease.

Vascular pharmacology·2025
Same author

Haematology dimension reduction, a large scale application to regular care haematology data.

BMC medical informatics and decision making·2025
Same author

Mechanical regulation of macrophage metabolism by allograft inflammatory factor 1 leads to adverse remodeling after cardiac injury.

Nature cardiovascular research·2025

Related Experiment Video

Updated: Apr 4, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.8K

Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery Function.

Nazanin Hakimzadeh1, A Yaël Nossent2, Anja M van der Laan3

  • 1Department of Biomedical Engineering & Physics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Plos One
|September 3, 2015
PubMed
Summary

MicroRNAs (miRNAs) in blood can identify patients with poor coronary collateral artery development. Elevated levels of miR423-5p, miR10b, miR30d, and miR126 indicate insufficient collateral capacity in chronic total occlusion patients.

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

6.0K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.9K

Related Experiment Videos

Last Updated: Apr 4, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.8K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

6.0K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.9K

Area of Science:

  • Cardiovascular Biology
  • Molecular Diagnostics
  • Biomarker Discovery

Background:

  • Coronary collateral arteries act as natural bypasses during coronary obstruction.
  • Collateral network development is crucial for patient outcomes after acute myocardial infarction (AMI).
  • MicroRNAs (miRNAs) are emerging as biomarkers and therapeutic targets in cardiovascular disease.

Purpose of the Study:

  • To identify differentially expressed miRNAs in chronic total occlusion (CTO) patients with varying degrees of coronary collateral artery development.
  • To assess the potential of identified miRNAs as circulating biomarkers for collateral capacity.

Main Methods:

  • Coronary angiography and collateral flow index (CFI) assessment in 41 CTO patients.
  • miRNA profiling of aortic plasma followed by quantitative reverse transcription polymerase chain reaction (RT-qPCR) validation.
  • Dichotomization of patients into low (CFI<0.39) and high (CFI>0.39) collateral capacity groups.

Main Results:

  • Four miRNAs (miR423-5p, miR10b, miR30d, miR126) were significantly elevated in patients with insufficient collateral network development (low CFI).
  • These four miRNAs demonstrated utility as circulating biomarkers to discriminate between patients with low and high collateral capacity.
  • miR30d and miR126 showed significantly greater expression in CTO patients compared to healthy controls.

Conclusions:

  • This study identifies specific miRNAs associated with coronary collateral capacity in CTO patients.
  • The identified miRNAs can serve as non-invasive biomarkers to assess collateral function.
  • This research is the first to link specific miRNAs to coronary collateral vessel function in humans.